发明名称 OPHTHALMIC COMPOSITIONS OF CARBONIC ANHYDRASE INHIBITORS FOR TOPICAL APPLICATION IN THE TREATMENT OF ELEVATED INTRAOCULAR PRESSURE
摘要 Although dibasic carbonic anhydrase inhibitors (C.A.I.) can be administered systemically by oral or intravenous routes, attempts to administer them topically were inadvisable because of their elevated pH. The mono-alkali metal salts in the treatment of intraocular hypertension especially the sodium and potassium salts, of dibasic salt-forming C.A.I. are as effective in lowering intraocular pressure as dialkali metal salts of dibasic C.A.I. while having a pH more in harmony with ocular pH. They are found particularly useful when administered in conjunction with an ophthalmologically acceptable water-soluble polymer such as hydroxypropylcellulose in an aqueous carrier.
申请公布号 DE3167999(D1) 申请公布日期 1985.02.14
申请号 DE19813167999 申请日期 1981.03.03
申请人 MERCK & CO. INC. 发明人 SMITH, ROBERT L.
分类号 A61K31/18;A61K9/00;A61K31/28;A61K31/41;A61K31/433;A61P27/02;C07D285/12;(IPC1-7):A61K9/06 主分类号 A61K31/18
代理机构 代理人
主权项
地址